XML 22 R5.htm IDEA: XBRL DOCUMENT v3.26.1
Condensed Consolidated Statements of Changes in Stockholders' Equity - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
Accumulated Deficit [Member]
Total
Balance at Dec. 31, 2024 $ 12,536 $ 201,103,311 $ (182,110,999) $ 19,004,848
Balance (in shares) at Dec. 31, 2024 37,987,380      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Stock-based compensation expense $ 0 1,253,882 0 1,253,882
Issuance of common stock for consulting agreement $ 50 203,451 0 203,501
Issuance of common stock for consulting agreement (in shares) 150,000      
Issuance of common stock from at-the-market program, net $ 68 306,047 0 306,115
Issuance of common stock from at-the-market program, net (in shares) 205,350      
Issuances of common stock, net of issuance costs $ 2,111 6,919,908 0 6,922,019
Issuances of common stock, net of issuance costs (in shares) 6,396,787      
Issuance of pre-funded warrants $ 0 1,009,969 0 1,009,969
Issuance of warrants 0 2,150,771 0 2,150,771
Exercise of pre-funded warrants $ 233 (162) 0 71
Exercise of pre-funded warrants (in shares) 706,334      
Net loss $ 0 0 (8,488,967) (8,488,967)
Balance at Mar. 31, 2025 $ 14,998 212,947,177 (190,599,966) 22,362,209
Balance (in shares) at Mar. 31, 2025 45,445,851      
Balance at Dec. 31, 2025 $ 18,111 225,840,226 (216,606,504) 9,251,833
Balance (in shares) at Dec. 31, 2025 54,878,233      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Stock-based compensation expense $ 0 1,156,495 0 1,156,495
Issuance of common stock for consulting agreement $ 0 0 0 0
Issuance of common stock for consulting agreement (in shares) 0      
Issuance of common stock from at-the-market program, net $ 309 833,062 0 833,371
Issuance of common stock from at-the-market program, net (in shares) 937,420      
Issuances of common stock, net of issuance costs $ 0 0 0 0
Issuances of common stock, net of issuance costs (in shares) 0      
Issuance of pre-funded warrants $ 0 0 0 0
Issuance of warrants 0 0 0 0
Exercise of pre-funded warrants $ 0 0 0 0
Exercise of pre-funded warrants (in shares) 0      
Net loss $ 0 0 (7,349,056) (7,349,056)
Balance at Mar. 31, 2026 $ 18,420 $ 227,829,783 $ (223,955,560) $ 3,892,643
Balance (in shares) at Mar. 31, 2026 55,815,653